Oral herpes is extremely common. An estimated 3.8 billion people under age 50, roughly 64% of the global population, carry herpes simplex virus type 1 (HSV-1), the strain responsible for most cold sores. In the United States, about 48% of people aged 14 to 49 test positive for HSV-1, based on the most recent national health survey data from the CDC.
Most People Never Get Cold Sores
The majority of people carrying HSV-1 have no idea they’re infected. The virus often causes no symptoms at all, or symptoms so mild they go unnoticed. Only a minority of carriers experience the classic cold sore outbreaks, those fluid-filled blisters that appear on or around the lips. This means the actual number of people living with the virus is far higher than the number who would ever identify themselves as having oral herpes.
When outbreaks do occur, they tend to follow a pattern. A first episode is usually the most severe, sometimes involving multiple sores, swollen gums, fever, and body aches. Recurrences are typically milder and shorter. Many people notice a tingling or burning sensation on the lip a day or two before a sore appears, which is the ideal window to start treatment.
How It Spreads, Even Without Symptoms
HSV-1 spreads primarily through direct skin-to-skin contact, most commonly kissing. It can also spread through sharing utensils, lip balm, razors, or towels, though this is less efficient. The virus can survive up to two hours on skin, three hours on cloth, and four hours on plastic surfaces, so transmission through objects is possible but requires fairly quick contact.
What makes HSV-1 so widespread is that the virus sheds from the skin even when no sore is visible. This “asymptomatic shedding” means a person can transmit the virus on days they feel completely fine and have no blisters. Research tracking viral shedding over time found the virus present on roughly 7% of days even nearly a year after a first infection, with the rate higher in the first few months. This invisible shedding is a major reason the virus is so prevalent globally.
HSV-1 Can Also Cause Genital Herpes
One fact that surprises many people: HSV-1 isn’t limited to the mouth. Through oral sex, it can be transmitted to a partner’s genitals and cause genital herpes. An estimated 10 to 15% of primary genital herpes cases are caused by HSV-1 rather than HSV-2 (the strain traditionally associated with genital infections). Among people who develop genital HSV-1, studies have found that 50 to 100% had received oral sex shortly before their outbreak.
Genital HSV-1 tends to recur less frequently than genital HSV-2, and shedding rates decline over the first year. But the initial outbreak can be just as uncomfortable, and the emotional impact of a genital herpes diagnosis is often significant regardless of which virus type caused it.
Why Rates Are Shifting
Interestingly, HSV-1 infection rates among younger adults in the U.S. have been declining over recent decades. Improved hygiene and less close physical contact in childhood mean fewer people are picking up the virus early in life, when infections are usually mild or silent. The U.S. prevalence of about 48% is notably lower than the global average of 64%.
This shift has an unexpected consequence. People who reach adolescence and adulthood without HSV-1 antibodies have no immune protection against the virus when they encounter it through kissing or oral sex. Some researchers believe this is contributing to the rise in genital HSV-1 cases among young adults, since their first exposure to the virus happens during sexual contact rather than during childhood.
Managing Cold Sore Outbreaks
For people who do get cold sores, antiviral medication can shorten outbreaks and reduce their severity. The most commonly prescribed option works best when taken at the very first sign of a sore, during that tingling or itching stage before a blister forms. A typical treatment course for a cold sore is just one day. People with frequent recurrences (six or more per year) can take a daily suppressive dose to reduce how often outbreaks happen and lower the risk of passing the virus to others.
Beyond medication, practical steps can reduce transmission risk. Avoiding kissing and sharing personal items during an active outbreak is the most straightforward measure. Using lip balm with sunscreen can help prevent outbreaks triggered by UV exposure, since sunlight is a well-known trigger alongside stress, illness, and fatigue.
No Vaccine Yet
Despite the virus affecting billions of people, there is no approved vaccine for HSV-1. Several candidates are currently in early to mid-stage clinical trials, including vaccines using traditional protein-based approaches and newer mRNA technology similar to what was used for COVID-19 vaccines. None have advanced to the final phase of testing required for approval, so a commercially available vaccine remains years away at best.
For now, HSV-1 remains a lifelong infection. The virus establishes itself in nerve cells after the initial infection and stays dormant between outbreaks. It cannot be cured or fully cleared from the body. But for the vast majority of carriers, it causes either no symptoms or occasional cold sores that are more of a nuisance than a serious health concern.